Natco Pharma Ltd.

BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
917.90
3.05 (0.33%)
< Home < Back

NATCO Pharma informs about press release

Date: 31-10-2025
NATCO Pharma has informed that it enclosed the Press Release under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.